α2-Macroglobulin-Mediated Degradation of Amyloid β1–42: A Mechanism to Enhance Amyloid β Catabolism
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in Experimental Neurology
- Vol. 167 (2) , 385-392
- https://doi.org/10.1006/exnr.2000.7569
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Evidence That Aβ42 Plasma Levels in Presenilin-1 Mutation Carriers Do not Allow for Prediction of Their Clinical PhenotypeNeurobiology of Disease, 1999
- Alpha-2 macroglobulin is genetically associated with Alzheimer diseaseNature Genetics, 1998
- α2‐Macroglobulin Attenuates β‐Amyloid Peptide 1–40 Fibril Formation and Associated Neurotoxicity of Cultured Fetal Rat Cortical NeuronsJournal of Neurochemistry, 1998
- Transport of Proteolytic Enzymes Across Caco-2 Cell MonolayersPharmaceutical Research, 1998
- Estrogen-stimulated transcytosis of desialylated ligands and α2 macroglobulin in rat liverBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1997
- Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intakeAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1997
- The Pathogenesis of Senile PlaquesJournal of Neuropathology and Experimental Neurology, 1997
- Modulation of the α2 macroglobulin receptor/low density lipoprotein receptor related protein by interferon-γ in human astroglial cellsJournal of Neuroimmunology, 1997
- α 2 “Macroglobulin, a multifunctional binding protein with targeting characteristicsThe FASEB Journal, 1992
- Absorption of exogenous and endogenousproteolytic enzymesClinical Pharmacology & Therapeutics, 1967